Vaccine Manufacturers, Human & Animal VaccinesVaccine Manufacturers, Human & Animal Vaccines

Who are the manufacturers of the Bordetella vaccine?

Major manufacturers of canine Bordetella vaccines include MSD Animal Health, Zoetis, and Boehringer Ingelheim Animal Health. Products are available in oral, intranasal, injectable, and combination formulations, depending on the market.

Answer

In veterinary medicine, “Bordetella vaccine” usually refers to vaccination against Bordetella bronchiseptica, an important component of canine infectious respiratory disease complex, commonly called kennel cough. Major manufacturers include MSD Animal Health, Zoetis, and Boehringer Ingelheim Animal Health.

Examples include:

• MSD Animal Health: Nobivac Intra-Trac products, including formulations combining Bordetella with canine parainfluenza virus and adenovirus type 2
• Zoetis: Vanguard B Oral and Bronchi-Shield products in applicable markets
• Boehringer Ingelheim: RECOMBITEK Oral Bordetella

The USDA product record identifies Vanguard B Oral as an avirulent live B. bronchiseptica vaccine, while Merck’s Nobivac Intra-Trac 3 ADT combines protection against several respiratory pathogens.

Product choice depends on the dog’s age, exposure to boarding or group settings, required onset of protection, administration route, previous vaccination, and local authorization. Oral and intranasal vaccines stimulate mucosal immunity, while injectable bacterins provide a different administration option. These formulations should not be assumed to have identical onset or duration of immunity.

Veterinary clinics and distributors must confirm storage requirements, minimum age, revaccination interval, combination antigens, and approved claims in the current label.

Dolores Carrillo Profile

Trust Our Expert Answers?

Build a Complete Veterinary Range

AdvaCare Pharma supports distributors with veterinary vaccines, medicines, pet products, and livestock solutions for diverse animal-health markets.

View Veterinary Portfolio

More questions on this topic